Rhoen-Klinikum AG (RHK.DE)
Bad Neustadt an der Saale, DE
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, delivers extensive healthcare services across Germany, encompassing inpatient, day-patient, and outpatient treatment models. The company's hospitals provide a broad spectrum of medical and surgical care, including cardiovascular rehabilitation, specialized hand and trauma surgery, neurological and psychosomatic treatments, addiction therapy, ophthalmology, and dentistry. They also address conditions affecting the thoracic region, lungs, and vascular system, offer oncology services, and manage neurological conditions, spinal column and joint issues, as well as heart diseases. The organization operates eight hospitals, providing a total of 5,420 beds or patient slots across five distinct medical locations. RHÖN-KLINIKUM is headquartered in Bad Neustadt an der Saale, Germany.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.38% | -3.91% | -0.81% | -6.82% | +0.82% | -4.65% | -3.91% | -3.91% | -20.65% | -54.50% | +39.77% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Care Facilities: +10.2%+21.3% ★ Q1'26: +5.2% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%-20.0% Q1'26: +72.7% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%-2.1% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%+0.2% Q1'26: +3.7% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%+0.3% Q1'26: +4.0% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%+0.0% Q1'26: +3.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×1.76× ★ Q1'26: 0.91× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2011 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2.63B
est: 2.68B (-2.0%)
|
2.86B
est: 2.88B (-0.7%)
|
3.01B
est: 3.09B (-2.5%)
|
1.51B
est: 1.44B (+4.9%)
|
1.11B
est: 1.11B (0.0%)
|
1.18B
est: 1.18B (-0.5%)
|
1.21B
est: 1.21B (+0.1%)
|
1.23B
est: 1.24B (-0.7%)
|
1.30B
est: 1.29B (+1.3%)
|
1.36B
est: 1.38B (-1.3%)
|
1.40B
est: 1.40B (-0.1%)
|
1.45B
est: 1.46B (-0.6%)
|
1.73B
est: 1.80B (-3.8%)
|
1.60B
est: 1.55B (+3.1%)
|
1.94B
est: 1.70B (+13.9%)
|
1.79B
1.79B – 1.79B
+5.3% YoY
|
1.88B
1.88B – 1.88B
+5.0% YoY
|
1.97B
1.97B – 1.97B
+5.0% YoY
|
2.07B
2.07B – 2.07B
+5.0% YoY
|
2.18B
2.18B – 2.18B
+5.0% YoY
|
| EBITDA |
364.86M
est: 260.94M (+39.8%)
|
298.83M
est: 319.92M (-6.6%)
|
279.09M
est: 240.66M (+16.0%)
|
1.42B
est: 91.87M (+1,445.7%)
|
158.21M
est: 972.72M (-83.7%)
|
158.10M
est: 147.10M (+7.5%)
|
97.04M
est: 84.32M (+15.1%)
|
125.64M
est: 95.08M (+32.1%)
|
125.56M
est: 124.72M (+0.7%)
|
80.66M
est: 125.78M (-35.9%)
|
100.21M
est: 130.04M (-22.9%)
|
106.15M
est: 132.05M (-19.6%)
|
116.58M
est: 116.99M (-0.3%)
|
122.23M
est: 100.41M (+21.7%)
|
69.40M
est: 110.34M (-37.1%)
|
116.19M
116.19M – 116.19M
+5.3% YoY
|
122.03M
122.03M – 122.03M
+5.0% YoY
|
128.13M
128.13M – 128.13M
+5.0% YoY
|
134.55M
134.55M – 134.55M
+5.0% YoY
|
141.24M
141.24M – 141.24M
+5.0% YoY
|
| EBIT |
222.06M
est: 202.43M (+9.7%)
|
157.67M
est: 229.19M (-31.2%)
|
158.09M
est: 168.48M (-6.2%)
|
1.34B
est: 72.54M (+1,743.6%)
|
97.15M
est: 1.04B (-90.6%)
|
98.30M
est: 99.40M (-1.1%)
|
37.92M
est: 99.33M (-61.8%)
|
65.14M
est: 39.68M (+64.2%)
|
57.14M
est: 67.42M (-15.3%)
|
11.24M
est: 60.48M (-81.4%)
|
30.56M
est: 62.53M (-51.1%)
|
37.62M
est: 63.50M (-40.8%)
|
51.40M
est: 42.09M (+22.1%)
|
59.60M
est: 36.13M (+65.0%)
|
4.39M
est: 39.70M (-88.9%)
|
41.80M
41.80M – 41.80M
+5.3% YoY
|
43.90M
43.90M – 43.90M
+5.0% YoY
|
46.10M
46.10M – 46.10M
+5.0% YoY
|
48.41M
48.41M – 48.41M
+5.0% YoY
|
50.81M
50.81M – 50.81M
+5.0% YoY
|
| Net Income |
156.11M
est: 142.90M (+9.2%)
|
89.69M
est: 167.80M (-46.6%)
|
86.65M
est: 100.55M (-13.8%)
|
1.23B
est: 40.34M (+2,938.1%)
|
85.38M
est: 956.73M (-91.1%)
|
56.43M
est: 91.12M (-38.1%)
|
35.15M
est: 57.79M (-39.2%)
|
48.99M
est: 36.04M (+35.9%)
|
43.28M
est: 50.98M (-15.1%)
|
1.45M
est: 45.96M (-96.8%)
|
28.30M
est: 47.52M (-40.5%)
|
25.14M
est: 48.26M (-47.9%)
|
38.71M
est: 46.53M (-16.8%)
|
43.35M
est: 34.81M (+24.5%)
|
34.47M
est: 42.17M (-18.3%)
|
42.84M
42.84M – 42.84M
+1.6% YoY
|
52.88M
52.88M – 52.88M
+23.4% YoY
|
59.57M
59.57M – 59.57M
+12.7% YoY
|
70.95M
70.95M – 70.95M
+19.1% YoY
|
83.00M
83.00M – 83.00M
+17.0% YoY
|
| SGA |
—
est: 1.77B (-100.0%)
|
38.70M
est: 1.92B (-98.0%)
|
41.00M
est: 2.24B (-98.2%)
|
23.50M
est: 989.23M (-97.6%)
|
15.50M
est: 867.13M (-98.2%)
|
19.60M
est: 851.54M (-97.7%)
|
21.30M
est: 891.02M (-97.6%)
|
22.90M
est: 930.24M (-97.5%)
|
24.20M
est: 944.45M (-97.4%)
|
24.20M
est: 1.05B (-97.7%)
|
20.20M
est: 1.09B (-98.1%)
|
21.70M
est: 1.10B (-98.0%)
|
4.80M
est: 57.62M (-91.7%)
|
69.40M
est: 49.46M (+40.3%)
|
162.95M
est: 54.35M (+199.8%)
|
57.23M
57.23M – 57.23M
+5.3% YoY
|
60.11M
60.11M – 60.11M
+5.0% YoY
|
63.11M
63.11M – 63.11M
+5.0% YoY
|
66.28M
66.28M – 66.28M
+5.0% YoY
|
69.57M
69.57M – 69.57M
+5.0% YoY
|
| EPS |
1.13
est: 1.14 (-0.5%)
|
0.65
est: 0.72 (-9.1%)
|
0.63
est: 0.75 (-16.3%)
|
9.36
est: 0.49 (+1,797.8%)
|
1.19
est: 1.07 (+11.5%)
|
0.84
est: 1.23 (-32.0%)
|
0.53
est: 0.52 (+1.9%)
|
0.73
est: 0.60 (+22.0%)
|
0.65
est: 0.37 (+77.3%)
|
0.02
est: 0.26 (-91.7%)
|
0.42
est: 0.44 (-5.3%)
|
0.38
est: 0.25 (+52.0%)
|
0.58
est: 0.70 (-16.6%)
|
0.65
est: 0.52 (+25.0%)
|
0.52
est: 0.63 (-17.5%)
|
0.64
0.64 – 0.64
+1.6% YoY
|
0.79
0.79 – 0.79
+23.4% YoY
|
0.89
0.89 – 0.89
+12.7% YoY
|
1.06
1.06 – 1.06
+19.1% YoY
|
1.24
1.24 – 1.24
+17.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 2/5 | 5/5 |
| 2026-05-11 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 2/5 | 5/5 |
| 2026-05-08 | A- | 4/5 | 5/5 | 2/5 | 4/5 | 3/5 | 2/5 | 5/5 |
| 2026-05-07 | A- | 4/5 | 5/5 | 2/5 | 4/5 | 3/5 | 2/5 | 5/5 |
| 2026-05-06 | A- | 4/5 | 5/5 | 2/5 | 4/5 | 3/5 | 2/5 | 5/5 |
| 2026-05-05 | A- | 4/5 | 5/5 | 2/5 | 4/5 | 3/5 | 2/5 | 5/5 |
| 2026-05-04 | A- | 4/5 | 5/5 | 2/5 | 4/5 | 3/5 | 2/5 | 5/5 |
| 2026-04-30 | A- | 4/5 | 5/5 | 2/5 | 4/5 | 2/5 | 2/5 | 5/5 |
| 2026-04-29 | A- | 4/5 | 5/5 | 2/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-28 | A- | 4/5 | 5/5 | 2/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-27 | A- | 4/5 | 5/5 | 2/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-24 | A- | 4/5 | 5/5 | 2/5 | 4/5 | 2/5 | 2/5 | 5/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 2/5 | 4/5 | 2/5 | 2/5 | 5/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 2/5 | 4/5 | 2/5 | 2/5 | 5/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 2/5 | 4/5 | 2/5 | 2/5 | 5/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 2/5 | 4/5 | 2/5 | 2/5 | 5/5 |
| 2026-04-17 | A- | 4/5 | 5/5 | 2/5 | 4/5 | 2/5 | 2/5 | 5/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 2/5 | 4/5 | 2/5 | 2/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Gunther Karl Weiß | Chief Operating Officer & Member of Management Board | 793.0K | — |
| Stefan Stranz | Chief Financial Officer & Member of Management Board | 700.0K | — |
| Eugen Münch | Chief Representative | — | male |
| Julian Schmitt | Head of Investor Relations & Treasury | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for RHK.DE
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
